Literature DB >> 21136220

Do tissues from THA revision of highly crosslinked UHMWPE liners contain wear debris and associated inflammation?

Ryan M Baxter1, Theresa A Freeman, Steven M Kurtz, Marla J Steinbeck.   

Abstract

BACKGROUND: Polyethylene wear debris is a major contributor to inflammation and the development of implant loosening, a leading cause of THA revisions. To reduce wear debris, highly crosslinked ultrahigh-molecular-weight polyethylene (UHMWPE) was introduced to improve wear properties of bearing surfaces. As highly crosslinked UHMWPE revision tissues are only now becoming available, it is possible to examine the presence and association of wear debris with inflammation in early implant loosening. QUESTIONS/PURPOSES: We asked: (1) Does the presence of UHMWPE wear debris in THA revision tissues correlate with innate and/or adaptive immune cell numbers? (2) Does the immune cell response differ between conventional and highly crosslinked UHMWPE cohorts?
METHODS: We collected tissue samples from revision surgery of nine conventional and nine highly crosslinked UHMWPE liners. Polarized light microscopy was used to determine 0.5- to 2-μm UHMWPE particle number/mm2, and immunohistochemistry was performed to determine macrophage, T cell, and neutrophil number/mm2.
RESULTS: For the conventional cohort, correlations were observed between wear debris and the magnitude of individual patient macrophage (ρ=0.70) and T cell responses (ρ=0.71) and between numbers of macrophages and T cells (ρ=0.77) in periprosthetic tissues. In comparison, the highly crosslinked UHMWPE cohort showed a correlation between wear debris and the magnitude of macrophage responses (ρ=0.57) and between macrophage and T cell numbers (ρ=0.68). Although macrophages and T cells were present in both cohorts, the highly crosslinked UHMWPE cohort had lower numbers, which may be associated with shorter implantation times.
CONCLUSIONS: The presence of wear debris and inflammation in highly crosslinked UHMWPE revision tissues may contribute to early implant loosening.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21136220      PMCID: PMC3126969          DOI: 10.1007/s11999-010-1713-x

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  74 in total

1.  Early osteolysis following second-generation metal-on-metal hip replacement.

Authors:  Youn-Soo Park; Young-Wan Moon; Seung-Jae Lim; Jun-Mo Yang; Geunghwan Ahn; Yoon-La Choi
Journal:  J Bone Joint Surg Am       Date:  2005-07       Impact factor: 5.284

Review 2.  Bone remodeling, particle disease and individual susceptibility to periprosthetic osteolysis.

Authors:  J Gallo; M Raska; F Mrázek; M Petrek
Journal:  Physiol Res       Date:  2007-04-25       Impact factor: 1.881

3.  Retrieval analyses of highly cross-linked polyethylene acetabular liners four and five years after implantation.

Authors:  K Knahr; M Pospischill; P Köttig; W Schneider; H Plenk
Journal:  J Bone Joint Surg Br       Date:  2007-08

Review 4.  Periprosthetic osteolysis: an immunologist's update.

Authors:  R John Looney; Edward M Schwarz; Allen Boyd; Regis J O'Keefe
Journal:  Curr Opin Rheumatol       Date:  2006-01       Impact factor: 5.006

5.  Human arthroplasty derived macrophages differentiate into osteoclastic bone resorbing cells.

Authors:  A Sabokbar; Y Fujikawa; S Neale; D W Murray; N A Athanasou
Journal:  Ann Rheum Dis       Date:  1997-07       Impact factor: 19.103

6.  Polyethylene particles of a 'critical size' are necessary for the induction of cytokines by macrophages in vitro.

Authors:  T R Green; J Fisher; M Stone; B M Wroblewski; E Ingham
Journal:  Biomaterials       Date:  1998-12       Impact factor: 12.479

7.  Distinct immunohistomorphologic changes in periprosthetic hip tissues from historical and highly crosslinked UHMWPE implant retrievals.

Authors:  Ryan M Baxter; Allyson Ianuzzi; Theresa A Freeman; Steven M Kurtz; Marla J Steinbeck
Journal:  J Biomed Mater Res A       Date:  2010-10       Impact factor: 4.396

8.  Total hip arthroplasties: what are the reasons for revision?

Authors:  Slif D Ulrich; Thorsten M Seyler; Derek Bennett; Ronald E Delanois; Khaled J Saleh; Issada Thongtrangan; Michael Kuskowski; Edward Y Cheng; Peter F Sharkey; Javad Parvizi; James B Stiehl; Michael A Mont
Journal:  Int Orthop       Date:  2007-04-19       Impact factor: 3.075

Review 9.  Aseptic loosening of total joint replacements: mechanisms underlying osteolysis and potential therapies.

Authors:  Yousef Abu-Amer; Isra Darwech; John C Clohisy
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

10.  Variation in cytokine genes can contribute to severity of acetabular osteolysis and risk for revision in patients with ABG 1 total hip arthroplasty: a genetic association study.

Authors:  Jiri Gallo; Frantisek Mrazek; Martin Petrek
Journal:  BMC Med Genet       Date:  2009-10-27       Impact factor: 2.103

View more
  5 in total

Review 1.  Contributions of human tissue analysis to understanding the mechanisms of loosening and osteolysis in total hip replacement.

Authors:  Jiri Gallo; Jana Vaculova; Stuart B Goodman; Yrjö T Konttinen; Jacob P Thyssen
Journal:  Acta Biomater       Date:  2014-02-10       Impact factor: 8.947

2.  [Which hip articulation bearing for which patient? : Tribology of the future].

Authors:  M M Morlock; N Bishop; C Kaddick
Journal:  Orthopade       Date:  2011-12       Impact factor: 1.087

3.  The role of oxidative stress in aseptic loosening of total hip arthroplasties.

Authors:  Marla J Steinbeck; Lauren J Jablonowski; Javad Parvizi; Theresa A Freeman
Journal:  J Arthroplasty       Date:  2013-11-26       Impact factor: 4.757

4.  CD11b promotes the differentiation of osteoclasts induced by RANKL through the spleen tyrosine kinase signalling pathway.

Authors:  Guoxi Yang; Xiaoyong Chen; Zhao Yan; Qingsheng Zhu; Chongfei Yang
Journal:  J Cell Mol Med       Date:  2017-06-29       Impact factor: 5.310

5.  Pyrroloquinoline quinine inhibits RANKL-mediated expression of NFATc1 in part via suppression of c-Fos in mouse bone marrow cells and inhibits wear particle-induced osteolysis in mice.

Authors:  Lingbo Kong; Chongfei Yang; Lifeng Yu; Wanli Smith; Shu Zhu; Jinyu Zhu; Qingsheng Zhu
Journal:  PLoS One       Date:  2013-04-17       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.